02717nas a2200721   4500000000100000008004100001260001200042653003300054653001600087653001300103653001300116100001100129700001200140700001200152700001200164700001600176700001400192700001300206700001600219700001100235700001500246700001400261700001300275700001500288700001400303700001400317700001200331700001000343700001300353700001200366700001300378700001400391700001700405700001500422700001300437700001300450700001300463700001200476700001100488700001500499700001200514700001400526700001300540700001300553700001400566700001300580700001200593700001200605700001500617700001200632700001400644700001200658700001600670700001800686700001400704700001400718700001300732700002100745245010800766856007300874520103400947022001401981       2020                            d  c09/202010a neglected tropical diseases10acoronavirus10amodeling10aCovid-191 aToor J1 aAdams E1 aAliee M1 aAmoah B1 aAnderson RM1 aAyabina D1 aBailey R1 aBasáñez M1 aBlok D1 aBlumberg S1 aBorlase A1 aRivera R1 aCastaño M1 aChitnis N1 aCoffeng L1 aCrump R1 aDas A1 aDavis CN1 aDavis E1 aDeiner M1 aDiggle PJ1 aFronterrè C1 aGiardina F1 aGiorgi E1 aGraham M1 aHamley J1 aHuang C1 aKura K1 aLietman TM1 aLucas T1 aMalizia V1 aMedley G1 aMeeyai A1 aMichael E1 aPorco TC1 aPrada J1 aRock KS1 aLe Rutte E1 aSmith M1 aSpencer S1 aStolk W1 aTouloupou P1 aVasconcelos A1 aVegvari C1 ade Vlas S1 aWalker M1 aHollingsworth DT00aPredicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation.  uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543306/pdf/ciaa933.pdf3 a<p>Due to the COVID-19 pandemic, many key neglected tropical disease (NTD) activities have been postponed. This hindrance comes at a time when the NTDs are progressing towards their ambitious goals for 2030. Mathematical modelling on several NTDs, namely gambiense sleeping sickness, lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases (STH), trachoma, and visceral leishmaniasis, shows that the impact of this disruption will vary across the diseases. Programs face a risk of resurgence, which will be fastest in high-transmission areas. Furthermore, of the mass drug administration diseases, schistosomiasis, STH, and trachoma are likely to encounter faster resurgence. The case-finding diseases (gambiense sleeping sickness and visceral leishmaniasis) are likely to have fewer cases being detected but may face an increasing underlying rate of new infections. However, once programs are able to resume, there are ways to mitigate the impact and accelerate progress towards the 2030 goals.</p>  a1537-6591